https://www.thebodypro.com/category/adverse-events-comorbidities-hiv/tag/conference-coverage

The Latest

Men With HIV Twice as Likely to Have Low Testosterone Img

Men With HIV Twice as Likely to Have Low Testosterone

Hypogonadism, or low testosterone, affected more than one in 10 HIV-positive men in a preliminary single-center study in France. That rate is two times higher than in the general population of similarly aged men.

TeleHealth Empowers Rural Clinicians to Treat HIV, HCV Locally Img

TeleHealth Empowers Rural Clinicians to Treat HIV, HCV Locally

In rural areas, scarce clinical resources exist for many people living with chronic infectious diseases -- or for the clinicians who provide care for them. But a program called Project ECHO is trying to turn that tide.

Promo Image

What's Hot in HIV Clinical Science

What are the hottest developments in HIV clinical science over the past year? Physician-researcher Adaora Adimora, M.D., M.P.H., brought us a brief tour of key highlights at the start of the IDWeek 2015 medical conference in San Diego.

Single-Tablet HIV Regimen Containing Tenofovir Alafenamide Improves Bone and Kidney Safety Img

Single-Tablet HIV Regimen Containing Tenofovir Alafenamide Improves Bone and Kidney Safety

A new single-tablet HIV regimen containing tenofovir alafenamide (TAF) offered better bone and kidney safety, according to a study presented at ICAAC/ICC 2015.

Douglas Dieterich on Latest Hepatitis C Drugs (Video) Img

Douglas Dieterich on Latest Hepatitis C Drugs (Video)

Douglas Dieterich, M.D., who specializes in liver disease at Mount Sinai Hospital, discusses the new generation of medications against hepatitis C (HCV).

HIV and Cardiovascular Disease Img

HIV and Cardiovascular Disease

This year at CROI, there were over 30 abstracts on cardiovascular disease and HIV, which is a noticeable increase from prior years. Here's a recap of some of those studies.

CROI 2015: HIV Metabolic Issues Panel (Video) Img

CROI 2015: HIV Metabolic Issues Panel (Video)

Handling metabolic issues in HIV-positive patients requires a "multifactorial solution particularly emphasizing lifestyle modification."

CROI 2015: The (Lack of) Response to the Ebola Epidemic (Video) Img

CROI 2015: The (Lack of) Response to the Ebola Epidemic (Video)

With the deaths of 500 health care workers in West Africa due to Ebola, the epidemic has brought on a public health emergency in a region that already has a shortage of care providers and resources.

Varenicline (Chantix) Helps HIV-Positive Individuals Quit Smoking but Overall Success Rates Low Img

Varenicline (Chantix) Helps HIV-Positive Individuals Quit Smoking but Overall Success Rates Low

The use of varenicline (Chantix) appears to be relatively safe in people living with HIV, and when combined with counseling, could significantly increase the number who are able to quit smoking, according to a CROI 2015 study.

Tenofovir Alafenamide (TAF) Gentler on the Bones and Kidneys Img

Tenofovir Alafenamide (TAF) Gentler on the Bones and Kidneys

The new formulation of tenofovir, tenofovir alafenamide (TAF), was associated with less harm to bones and kidneys than the older formulation, tenofovir disoproxil fumarate (TDF, Viread).